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The activity-dependent regulation of -amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA)-type glutamate receptors and
the stabilization of synapses are critical to synaptic development
and plasticity. One candidate molecule implicated in maturation,
synaptic strengthening, and plasticity is PSD-95. Here we find that
acute knockdown of PSD-95 in brain slice cultures by RNAi arrests
the normal development of synaptic structure and function that is
driven by spontaneous activity. Surprisingly, PSD-95 is not neces-
sary for the induction and early expression of long-term potenti-
ation (LTP). However, knockdown of PSD-95 leads to smaller
increases in spine size after chemically induced LTP. Furthermore,
although at this age spine turnover is normally low and LTP
produces a transient increase, in cells with reduced PSD-95 spine
turnover is high and remains increased after LTP. Taken together,
our data support a model in which appropriate levels of PSD-95 are
required for activity-dependent synapse stabilization after initial
phases of synaptic potentiation.
AMPA receptor  long-term depression  long-term potentiation 
postsynaptic density
Modifications in synaptic strength and stabilization of synapsesunderlie developmental and activity-dependent plasticity in
the brain. Understanding their molecular mechanisms provides
insight into behavioral plasticity and brain dysfunction during
disease. One postsynaptic modification regulating synaptic strength
is the delivery and removal of -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)-type glutamate receptors (1–4).
Recently, PSD-95, a member of the MAGUK (membrane-
associated guanylate kinase) family, has been suggested to play
important roles in synaptic plasticity in hippocampus and cortex by
regulating AMPA-R trafficking. These studies used overexpression
of wild-type and mutant forms of PSD-95 and suggested that
PSD-95 drives synaptic maturation, controls AMPA-R number at
synapses, and participates in receptor delivery or stabilization
during synaptic plasticity in vitro and in vivo (5–9). Moreover,
stronger synapses with increased PSD-95 levels show enhanced
synaptic depression [long-term depression (LTD)] (7, 8). Because
MAGUKs are highly homologous and several of them are present
at hippocampal synapses (10, 11), issues of specificity weaken the
conclusions of such studies. Predictions from overexpression ex-
periments are that loss of PSD-95 should affect basal synaptic
properties and strength as well as bidirectional synaptic plasticity.
However, a genetic approach using mice modified at the PSD-95
locus showed enhanced long-termpotentiation (LTP) and impaired
learning (12) but no change in basal synaptic function, which might
be due to undetected compensatory mechanisms. Here we exam-
ined the function of endogenous PSD-95 by a temporally and
spatially restricted knockdown approach using RNAi.
We find that knockdown of PSD-95 arrests the functional and
morphological development of glutamatergic synapses. Al-
though induction and early LTP are largely unaffected, spine
morphological changes are reduced and spines are less stable
over longer time periods. Our results suggest that PSD-95 is
required for receptor and synapse stabilization during develop-
ment and after activity-driven synaptic potentiation.
Results
We designed short hairpin RNAs (shRNAs) that knocked down
recombinant PSD-95 in heterologous cells (data not shown) and
confirmed their efficacy against endogenous PSD-95 in neurons.
After global transfection in hippocampal cultures, effective (Hp1
and Hp2), but not a control (Scr1), shRNA reduced PSD-95
expression in Western blots [supporting information (SI) Fig. 8 a
and b]. Using sparse transfection, effective shRNA also reduced
PSD-95 immunoreactivity in somata and dendrites of transfected
vs. neighboring control neurons in culture (SI Fig. 8 c and d).
Importantly, expression of Hp1 for 2–3 days in slice cultures also
reduced PSD-95 immunoreactivity in individual spines of CA1
neurons. Compared with GFP-expressing neurons, the fraction of
spines with undetectable levels of PSD-95 increased 2-fold, and
in spines with immunoreactivity, levels decreased2- to 3-fold (SI
Fig. 9). We also validated this method by confirming that overex-
pression increased PSD-95 immunoreactivity in all spines (SI Fig.
9). Although the morphology of shRNA-transfected neurons ap-
peared normal, we were concerned about off-target effects (13) or
interference with miRNA pathways (14) that could perturb gross
morphology and membrane properties. This is unlikely, because
two measures of these effects, input resistance and membrane
capacitance, were not altered by shRNA expression (SI Fig. 10).
Last, because PSD-95 can interact with K channels (10), knock-
down could affect passive and active membrane properties. How-
ever, current-clamp measurements of membrane potential, input
resistance, and spiking behavior show no significantly changes (SI
Fig. 11). In summary, our shRNAs have no adverse effects on
morphology or passive and active electrical properties of neurons
that would compromise data interpretation.
Knockdown of PSD-95 Decreases Synaptic Strength. If PSD-95 par-
ticipates in synaptic maturation and regulation of synaptic
strength, acute knockdown should decrease synaptic transmis-
sion. To prevent effects on early synaptogenesis and network
activity, we perturbed PSD-95 in a few neurons per slice, and
after initial synaptic connectivity in the hippocampus has been
established (15, 16). Consistent with our hypothesis, and com-
plementary to findings that overexpression increases synaptic
strength (6, 7, 9), acute knockdown of PSD-95 by Hp1 led to a
decrease in AMPA-mediated excitatory postsynaptic currents
(EPSCs) in CA1 neurons (Fig. 1 a and d). This decrease in
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AMPA-EPSCs was accompanied by a smaller decrease in the
late EPSC component at40 mV, mediated by NMDA-Rs (Fig.
1 a and e). Importantly, a second shRNA (Hp2) directed against
PSD-95 had the same effect, whereas a control shRNA (Scr1) did
not effect synaptic transmission (Fig. 1 b–e). To investigate
whether a subunit switch underlay or accompanied the apparent
change in NMDA currents, we recorded pharmacologically
isolated NMDA-EPSCs. Both the peak amplitude and the late
component decreased similarly (SI Fig. 12a). Decay kinetics and
susceptibility to the NR2B subunit-specific antagonist Ifenprodil
were not altered (SI Fig. 12 b and c), suggesting no detectible
change in properties of synaptic NMDA-Rs over 3 days. To
characterize the relationship between changes in AMPA-EPSCs
and NMDA-EPSCs and time course of synaptic depression, we
recorded 2–7 days after PSD-95 knockdown. Initially, the de-
crease in AMPA-EPSCs was significantly larger than for
NMDA-EPSCs and associated with a lower AMPA/NMDA
ratio. Later, AMPA-EPSCs and NMDA-EPSCs were similarly
altered with no change in AMPA/NMDA ratio (SI Fig. 13 a and
b). Our hypothesis is that initial changes in strength of AMPA-
EPSCs are followed by changes in NMDA-EPSCs and, conse-
quently, readjustment of AMPA/NMDA ratios (17–19). Thus,
we subsequently focused on effects of early knockdown (2–3
days).
Knockdown of PSD-95 Prevents the Developmental Increase in Syn-
apses with Functional AMPA-Rs. Excitatory synapses in the hip-
pocampus undergo activity-dependent changes within several
days in vivo or in vitro, among them increases in AMPA/NMDA
ratio of evoked transmission and in frequency of AMPA min-
iature EPSCs (mEPSCs) (16, 17, 19). Together with immuno-
labeling results (20), this suggested an increase in synapses
containing functional AMPA-Rs. One possibility is that knock-
down of PSD-95 prevents the developmental increase in func-
tional synapse number. Alternatively, the number of synapses
could increase, but the amount of functional receptors could be
reduced by other mechanisms, or a combination of decrease in
synapse and receptor number. To distinguish between these
possibilities, we compared amplitudes and frequencies of
AMPA-mEPSCs. We detected an increase in mEPSC frequency
between 6 and 7 days in vitro (Div) and 9 and 10 Div, which was
absent in neurons with knockdown of PSD-95 for 3 days (Fig. 2
a and b). There was no detectable change in mEPSC amplitude
(Fig. 2c). Thus, our results support the hypothesis that loss of
PSD-95 prevents the developmental increase in the number of
synapses expressing functional AMPA-Rs.
Knockdown of PSD-95 Prevents Developmental Changes in Spine
Density and Morphology. Concomitant with changes in synaptic
strength, activity drives spine morphological changes during
development and plasticity; e.g., large mushroom spines become
more prominent and may be associated with mature synapses of
high strength (16, 21–23). We wondered whether knockdown of
PSD-95 also perturbed changes in spine morphology.We imaged
spines at 7 Div and determined how they changed when neurons
expressed control (Scr1) or effective shRNA (Hp1) for 3 days
(Fig. 3a). Between 7 and 10 Div, we found a significant increase
in spine density and spine size that was absent when PSD-95 was
knocked down (Fig. 3 b and d). In addition and consistent with
previous findings (16, 23), stubby spines became less, and
mushroom spines became more frequent, a process that was also
prevented by PSD-95 knockdown (Fig. 3c). Interestingly, cumu-
lative distributions show a uniform shift (except for very large
spines which were rare but present in all groups), indicating that
the entire population shifted, rather than a selective change in
a subpopulation of spines. Our findings that knockdown of
PSD-95 not only prevented increases in synaptic strength but also
changes in spine density and morphology, suggest that synapses
may be arrested in a more immature state. Corresponding
changes in spine density and mEPSC frequency are consistent
with a reduction in functional synapse number.
Activity Blockade Occludes the Decrease in Glutamatergic Function by
Knockdown of PSD-95. Because knockdown of PSD-95 appears to
arrest processes at glutamatergic synapses that are normally driven
by spontaneous activity and NMDA-R activation (17, 19), one
prediction is that activity blockade should occlude the effects of
knockdown of PSD-95. To test this directly, we knocked down
PSD-95 in slices maintained in drugs that block neuronal activity.
If occlusion occurs, evoked EPSCs should not differ between
control and nearby knockdown neurons. Indeed, we found that
block of spontaneous activity by high Mg2 or TTX occluded both
the decrease synaptic strength of AMPA-EPSCs and NMDA-
Fig. 1. Knockdown of PSD-95 decreases synaptic strength. (a–c) EPSCs re-
corded from pairs of CA1 pyramidal neurons at 60 or 40 mV (one control
and one expressing shRNA). (a and b) Hp1 and Hp2 decreased AMPA-EPSCs
and, to a lesser extent, NMDA-EPSCs. (c) Scr1 had no effect on transmission.
(Scale bars: 50 pA and 40 ms.) (d) For Hp1 and Hp2, AMPA-EPSCs decreased to
57.9  11.4% (n  22, P  0.001) and to 70.2  9.4% of control (n  12, P 
0.05); there was no change for Scr1 (107.6  14.0%, n  14, P  0.83). (e) For
Hp1 and Hp2, NMDA-EPSCs decreased to 71.1 13.3% (n 24, P 0.02) and
to 75.6  15.1% of control (n  11, P  0.01); there was no change for Scr1
(92.3  20.2%, n  14, P  0.68).
Fig. 2. Knockdown of PSD-95 prevents the developmental increase in syn-
apses with functional AMPA-Rs. (a) AMPA-mEPSCs recorded at 60 mV from
CA1neuronsat 6Div and9Div (one control andoneexpressingHp1 for 3days).
(Scale bars: 20 pA and 50ms.) (b) The increase inmEPSC frequency from0.36
0.06 Hz (n 13) to 0.83 0.12 Hz (n 11) (P 0.001) was prevented by Hp1
(0.46  0.06 Hz, n  11, P  0.01 vs. 9 Div). (c) There was no difference in
average mEPSC amplitude in a cell-wise comparison (6 Div: 10.7 0.2 pA, n
13; 9 Div Con: 11.0 0.5 pA, n 11; 9 Div Hp1: 9.9 0.6 pA, n 11; P 0.15).








EPSCs (Fig. 4 a, b, d, and e). Consistent with a role for NMDA-R
signaling, 2-amino-5-phosphonovaleric acid (APV) also occluded
the decrease of AMPA-EPSCs (Fig. 4 c and d). Interestingly,
NMDA-EPSCs were still decreased (Fig. 4e), which may indicate
different requirements for the maintenance of NMDA-Rs or silent
synapses, containing NMDA-Rs only. Taken together, our results
lend support to the idea that PSD-95 participates in activity-driven
increases in glutamatergic function.
Normal Levels of PSD-95 Are Not Required for Induction and Early
Expression of LTP. Synaptic strengthening by spontaneous activity
and LTP share some similar mechanisms (19, 24, 25). Previous
studies have suggested that PSD-95 participates in LTP (8, 9).
We thus examined functional changes after pairing-induced LTP
in control (nontransfected or Scr1-expressing) and Hp1-
expressing neurons. In another set of experiments, we prevented
the decrease in NMDA-EPSCs by preincubating slice cultures in
TTX (cf. Fig. 4). Surprisingly, in all conditions, time course and
relative levels of LTP were not significantly altered 35 min after
pairing (Fig. 5 a, b, and e). Postsynaptic signaling mediating LTP
switches from being PKA- to being CaMKII-dependent, a
developmental process that is normally completed in the second
postnatal week, i.e., before we perform our experiments (24–26).
We explored the possibility that LTP in PSD-95 knockdown cells
uses more ‘‘immature’’ signaling mechanisms. However, we find
that blocking CaMKII-activity prevented induction and expres-
sion of LTP in both groups (Fig. 5 c–e). We conclude that normal
PSD-95 levels are not required for CaMKII-dependent induction
and expression of functional changes during the first 35 min
of LTP.
Knockdown of PSD-95 Affects Spine Morphological Changes After
cLTP. Because reducing PSD-95 levels arrested spine morpho-
logical changes over the course of days, we wondered whether it
also affects activity-driven changes on a shorter timescale. We
induced global potentiation of synapses using a chemical LTP
protocol (cLTP) that shares properties with electrically evoked
LTP (22, 27) and followedmodifications of spines by two-photon
imaging. We used older cultures in these experiments (see
methods), after confirming that Hp1 was still effective at reduc-
ing PSD-95 levels (SI Fig. 9) and synaptic strength (SI Fig. 13 c
and d). Consistent with previous results, we find that in control
neurons, spines present during the entire imaging session in-
creased their volume on average by 50% (22). In neurons
expressing Hp1 for 3 days, the increase in spine size was
significantly reduced (Fig. 5 f and g).
Interestingly, several other observations in these experiments
suggested that spines were less stable after PSD-95 knockdown.
In control neurons, almost all spines observed during baseline
persisted for the entire imaging session (98  1.0%, n  4 cells,
312 spines), whereas in Hp-expressing neurons this fraction was
Fig. 3. Knockdown of PSD-95 arrests spine morphological development. (a)
Two-photon images of secondary apical dendrites at 7 Div, and at 10 Div after
expressing control or effective shRNA for 3 days. (Scale bar: 2 m.) (b) Hp1
prevented the increase in spine density (*, P 0.01). Primary dendrites: 0.55
0.03 (7 Div), 0.84 0.04, and 0.54 0.05 spines per micrometer (Con and Hp1
at 10Div). Secondarydendrites: 0.550.02 (7Div), 0.840.04, and0.620.05
spines permicrometer (Con and Hp1 at 10 Div). Tertiary dendrites: 0.53 0.02
(7 Div), 0.72 0.05, and 0.52 0.04 spines permicrometer (Con and Hp1 at 10
Div). No difference was observed between 7 Div and Hp1 at 10 Div (P 0.13).
(c) Hp1prevented changes in spine type (*,P0.05). Fractionof stubby spines:
0.43  0.01 (7 Div), 0.30  0.03, and 0.44  0.02 (Con and Hp1 at 10 Div).
Fraction of mushroom spines: 0.33 0.02 (7 Div), 0.40 0.02, and 0.32 0.03
(Con and Hp1 at 10 Div). The fraction of thin spines did not change (P 0.16).
(d) Hp1 prevented spine size changes (*, P  0.04). Average spine sizes were
59.8 7.9 (7 Div), 84.1 9.7 (Con 10 Div), and 61.1 4.7 (Hp1 10 Div; P 0.44
vs. 7Div) in arbitrary units (AU). (Right) Cumulative distributions of spine sizes.
n  6 cells per group.
Fig. 4. Decrease in synaptic strength by knockdown of PSD-95 is occluded by
activity blockade. (a–c) EPSCs recorded from pairs of CA1 neurons at 60 or
40 mV after incubation in high Mg2, TTX, or APV for 2–3 days showed no
change, except for NMDA-EPSCs after incubation in APV. (Scale bars: 20 pA
and 40 ms.) (d) In Hp1-expressing neurons, AMPA-EPSCs were 99.8  15.3%
(34.1 6.0 vs. 34.0 5.2 pA, n 13, P 0.98) for TTX-treated neurons, 85.0
12.7%(34.73.1 vs. 29.53.8pA,n17,P0.23) forMg2-treatedneurons,
and 100.7  10.9% of control (27.2  2.2 vs. 27.4  3.0 pA, n  12, P  0.96)
for APV-treated neurons. (e) In Hp1-expressing neurons, NMDA-EPSCs were
91.6  21.1% (18.3  2.5 vs. 16.7  3.5 pA, n  12, P  0.38) for TTX-treated
neurons, 101.5  16.7% (17.7  2.8 vs. 18.0  3.0 pA, n  12, P  0.93) for
Mg2-treated neurons, and 68.2 13.6% of control (15.1 1.9 vs. 10.2 1.5
pA, n  10, P  0.02) for APV-treated neurons.
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significantly reduced (85  0.5%, n  4 cells, 327 spines) (P 
0.001). After cLTP, there was a larger fraction of transient spines
(lifetime 1 h) in knockdown vs. control neurons, and transient
spines were smaller than stable spines (Fig. 6 a and c). Last, the
number of spine additions and losses, the turnover rate (TOR),
was significantly increased after knockdown of PSD-95, both
before and after cLTP (Fig. 6b). In knockdown neurons, the high
TOR was due to approximately equal contribution of spine
addition and loss and resulted in little change in absolute spine
number. In control neurons, the TOR increased transiently after
cLTP (Fig. 6b), reflecting mostly addition of spines. In summary,
knockdown of PSD-95 resulted in decreased spine size changes
and a larger number of transient spines after cLTP, suggesting
that stabilization of spine morphological changes may be
impaired.
Increased Spine Turnover After Knockdown of PSD-95 Resembles That
in Younger Neurons. Next we explored the possibility that spines
in PSD-95 knockdown neurons were also less stable during
spontaneous activity. This may reflect behavior of spines in
younger neurons, where transient and motile protrusions are
prominent, and probe the neuropil for synaptic partners (28).We
determined TOR and fraction of transient spines during basal
activity in neurons age-matched to cLTP experiments (14 Div
plus 3 days with or without knockdown of PSD-95) during basal
activity, and compared those groups to younger neurons (Div12).
We found that both transient spines and spine TOR decreased
with development (Fig. 6 d–f ). When PSD-95 was knocked
down, the TOR remained elevated at levels observed in young
neurons, but the fraction of transient spines was even larger (Fig.
6 e and f ). These small transient spines resembled motile
protrusions not associated with PSD-95 clusters (29, 30). Our
results suggest that knockdown of PSD-95 not only impaired
spine changes after cLTP, but also decreased spine stability
during spontaneous activity, which could underlie the observed
arrest of synaptic stabilization and maturation.
Knockdown of PSD-95 Impairs LTD. Synapses are bidirectionally
regulated by activity and may have certain requirements for
Fig. 5. Knockdown of PSD-95 affectsmorphological but not early functional
changes during LTP. (a–e) Normal levels of PSD-95 are not required for
inductionandearly expressionof LTP. (a)Nodifference inLTPbetweencontrol
(nontransfected,n 10) andHp1-expressing (n 8) (P 0.23) neurons. (c) LTP
in control and Hp1-expressing neurons was sensitive to the CaMKII blocker
KN-93 applied 20 min before and during induction. (b and d) Average EPSCs
before and30–35minafter pairing. (Scale bars: 20pAand20ms.) (e) Summary
of all LTP data: When preincubation in TTX was used to prevent decrease in
NMDA-EPSCs, no difference in LTPwas observed (nontransfected: 2.46 0.31,
n 7; Scr1: 2.10 0.37, n 7; Hp1: 2.27 0.48, n 8; P 0.46). Under normal
conditions, LTP was 1.9  0.14 (n  10) in control neurons and blocked by
KN-93 (1.31 0.21, n 9, P 0.03). In Hp1 neurons, LTP was 2.26 0.28 (n
8) and blocked by KN-93 (1.23  0.21, n  7, P  0.02). ( f and g) Knockdown
of PSD-95affects spine size changes after cLTP. ( f) Spine changes (arrowheads)
after cLTP in a control and a Hp1-neuron. (Scale bars: 1 m.) (g) cLTP led to
smaller increases in spine volume inHp1 (26 4%, n 3 cells, 216 spines) than
in control neurons (46  7%, n  3 cells, 171 spines) (P  0.04).
Fig. 6. Knockdown of PSD-95 increases spine turnover and transient spines.
(a) Dendrite of Hp1 neuron imaged 30–90 min after cLTP showing extension
and retraction of protrusions (arrows). (Scale bar: 2 m.) (b) Spine TOR before
and after cLTP increased in Hp1 vs. control neurons (*, P 0.04; n 4 cells). In
controlneurons, TOR increased transiently after cLTP (**,P0.05). (c) Fraction
of transient spines (lifetime 1 h) after cLTP was increased in Hp1 vs. control
neurons (0.0100.002 vs. 0.0540.006 spines permicrometer per 30min,n
4 cells, P  0.01). Transient spines were smaller (normalized to mean stable
spine size; Con: 0.65 0.10, n 25; Hp1: 0.57 0.04, n 69). (d) Dendrite of
a control neuron (12 Div) showing transient protrusions (arrows). (Scale bar: 2
m.) (e) Basal TOR decreased over development and remained high after
knockdown (12 Div: 0.063 0.006, n 3; 17 Div Con: 0.013 0.007, n 5; 17
Div Hp1: 0.076  0.016 spines per micrometer per 30 min, n  4 cells; *, P 
0.006). ( f) The fraction of transient spines decreased but was elevated in Hp1
vs. control neurons (12Div: 0.043 0.006,n 3; 17Div Con: 0.008 0.006,n
5; 17 Div Hp1: 0.071  0.004 spines per micrometer per 30 min, n  4 cells; *,
P  0.012). Transient spines were smaller (12 Div: 0.55  0.06, n  29; Hp1:
0.44  0.05, n  25).








weakening to occur (31). Studies in culture have linked removal
of PSD-95, or signaling through PSD-95-associated complexes
(32–35) to loss of AMPA-Rs, and suggested this may underlie
synaptic depression. Here we tested directly whether knockdown
of PSD-95 affects LTD in slice cultures. We find that pairing-
induced LTD reduced AMPA-EPSCs by 50% in control cells,
but no LTD was observed in neurons from sister cultures that
expressed Hp1 (Fig. 7). Regardless of the precise mechanism,
our data suggest that PSD-95 is important in mediating some
aspect of LTD.
Discussion
Remodeling of synapses and modification of their strength
underlie activity-dependent plasticity. We addressed the func-
tion of PSD-95 in these processes using RNAi knockdown in slice
cultures at a period in development when activity drives synaptic
changes. With the surrounding network intact, we asked how
individual neurons respond to transient loss of PSD-95. We show
that appropriate levels of PSD-95 are required for regulation of
synaptic strength and functional maturation of synapses that is
normally driven by spontaneous activity. Furthermore, PSD-95
participates in the accompanying structural changes in spine
density and morphology. After LTP, synaptic transmission can
be transiently potentiated, but spine restructuring and stabiliza-
tion are impaired when PSD-95 is knocked down. Last, appro-
priate levels of PSD-95 appear critical for LTD to occur.
In contrast to previous work showing specific regulation of
AMPA-mediated EPSCs by PSD-95 (36, 37), we find that
NMDA-EPSCs are also moderately reduced. Factors such as
onset, length, and efficacy of altering PSD-95, as well as the
number of manipulated neurons in the network, may affect
outcome. Failure to acquire or stabilize AMPA-Rs could ulti-
mately lead to synaptic loss. Because most synapses in CA1 are
thought to contain NMDA-Rs (38, 39), an initial decrease in
AMPA-Rs could cause subsequent reduction in NMDA-Rs.
Consistent with this, coregulation of AMPA-EPSCs and
NMDA-EPSCs has been reported (17, 18). Knockdown of
PSD-95 could also attenuate generation of new silent synapses.
If formation of silent synapses does not require NMDA-R
activation, this may explain why APV treatment did not occlude
the decrease of NMDA-EPSCs in knockdown neurons.
All synaptic features investigated differed in knockdown neu-
rons and age-matched controls but precisely mimicked those of
younger neurons at onset of knockdown. One interpretation is
that loss of PSD-95 arrests synaptic development, and appro-
priate levels of PSD-95 are required for maturation, and for
plastic changes to proceed. Consistent with this idea, PSD-95
levels and synaptic localization increase during development, in
response to activity, or after learning (11, 40, 41), and multiple
mechanisms for activity-dependent transcription and translation
were identified (42–44). After blocking spontaneous activity for
2–3 days [which prevents increases in AMPA-containing syn-
apses (17, 19)], we no longer detect an effect of knockdown in
paired recordings, which we interpret as occlusion. A similar
protocol of activity blockade resulted in decreased synaptic
PSD-95 without affecting turnover, whereas other MAGUKs
were not regulated or were differently regulated (41). This
suggests that over the course of days, activity may control relative
abundance of PSD-95 at a population of synapses and their
maturation, whereas knockdown of PSD-95 and activity block-
ade would block maturation in a similar way.
Although turnover of PSD-95 at synapses is thought to be slow
(24–36 h) (32, 41), we found a significant reduction of PSD-95
levels at spines within 2–3 days. At least some of these spines
harbor synapses with normal AMPA-R content (mEPSC size is
not altered), suggesting that other mechanisms or MAGUKs
participate in maintenance of theses synapses and receptors. If
hippocampal synapses are challenged in mutant mice (12, 45) or
by molecular replacement in cultures (37), MAGUKs can com-
pensate for each other in maintaining transmission. Only a
combination of knockout/knockdown strategies can elucidate
the role for each individual MAGUK.
Overall, our findings are complementary to overexpression stud-
ies (6–9) and show bidirectional modification of synaptic transmis-
sion and spine morphology by transient changes in PSD-95. They
suggest that the prime mechanism for regulating synaptic strength
is PSD-95’s ability to control the number of synapses expressing
functional AMPA-Rs. Two manipulations that interfere with en-
dogenous PSD-95 either by knockdown in slice cultures (this study)
or expression of dominant negative PSD-95 in vivo (9) consistently
prevented activity-driven changes in synaptic strength over the
course of days. However, they had different effects on pairing-
induced LTP in slice cultures: Whereas knockdown did not alter
LTP30min after induction, expression of dnPSD-95 impairedLTP
at this timescale. It is possible that knockdown (several days) and
expression of dn PSD-95 (12–24 h) affect induction differently.
First, signaling at smaller spines (knockdown) could be altered by
spine geometry affecting calcium dynamics (46) to enable mecha-
nisms that rescue induction. Another explanation is that PSD-95
may be normally recruited during induction and this is important
for subsequent stabilization of synaptic changes, but not for initial
potentiation. Because dn PSD-95 could be recruited during induc-
tion, its abnormal structure would also lead to disruption of initial
potentiation. In the case of knockdown, absence of PSD-95 would
not affect initial potentiation but would affect only subsequent
stabilization of synaptic weight changes. In this model, increases in
PSD-95 levels at spines after overexpression would bypass its
recruitment during induction and result in stable potentiation,
which occludes subsequent LTP.
Increased strength is accompanied by structural changes after
LTP (21), and structural remodeling is proposed to lock in initial
synaptic weight changes on the timescale of hours and days (31).
Consistent with this model, compromised structural changes and
spine stabilization during knockdown could lead to the observed
failure to stabilize increases in synaptic strength over several
days. It also suggests that PSD-95 signaling or availability at
synapses may serve as one link between early and long lasting,
stable changes at synapses. In contrast to overexpression, where
LTD was enhanced, (7, 8), decreasing PSD-95 levels resulted in
the absence (or severe reduction) of LTD, suggesting PSD-95
content at synapses may be one of the factors determining their
ability to undergo LTD. We cannot discriminate whether this is
attributable to block or occlusion, but both scenarios are con-
sistent with PSD-95 mediating some aspect of LTD.
In conclusion, our study using a knockdown approach indi-
cates that PSD-95 is critical for several aspects of activity-
dependent structural and functional plasticity. Because PSD-95
is a multidomain molecule, further work, e.g., using molecular
Fig. 7. Knockdown of PSD-95 impairs LTD. (a) Synaptic depression after
pairing-induced LTDwasnotdetected inHp1-expressingneurons. (b) Average
AMPA-EPSCs at60 mV recorded before and 30–35 min after LTD induction.
(Scale bars: 20 pA and 20 ms.) (c) Summary of changes after LTD: In control
neurons, EPSCs decreased to 0.51  0.08 of baseline (n  11), significantly
different fromHp1 (0.980.18,n7,P0.02). Control pathwayswere stable
(0.92  0.16 and 0.98  0.19).
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replacement strategies with mutant forms of PSD-95, may reveal
how different domains and interactions participate in different
aspects of PSD-95 function.
Methods
Constructs and Expression. Two sequences from rat PSD-95
mRNA (GenBank accession no. M96853) were targeted with
shRNAs: Hp1, AATACCGCTACCAAGATGAAGACACG-
CCC; Hp2, ACATCTGGGTCCCAGCCCGAGAGAGACTC.
Constructs with the human RNA polymerase III promoter
driving hairpin expression were generated by PCR with
pGEMSP6-Zeo-U6 (provided by G. Hannon, Cold Spring Har-
bor Laboratory, Cold Spring Harbor, NY) as template and
cloned into pBluescript (Stratagene, La Jolla, CA) . The control
shRNA (Scr1) targeted AGAACACACGCAATCGAGCAC-
CCTAGATC, a sequence not present in known rat genes or
ESTs. We coexpressed shRNAs with GFP (pEGFP-C1; Clon-
tech,Mountain View, CA) at a 3:1 ratio by biolistic gene transfer.
Expression was 2–3 days in all experiments, except for SI Fig. 13.
Slice Cultures and Pharmacological Treatments. Hippocampal slice
cultures were prepared from postnatal day 6–7 rats as described
(9) and maintained for 1 week before transfection unless
otherwise stated. In some experiments, activity was blocked by
adding 10 mM MgCl2 (Sigma, St. Louis, MO), 1 M TTX
(Calbiochem, San Diego, CA), or 100 M D,L-APV (Sigma) to
the culture medium at transfection.
Electrophysiology. Whole-cell recordings were obtained simulta-
neously from neighboring control and transfected CA1 neurons,
and EPSCs were evoked, acquired, and analyzed as described
(9). LTP was induced by pairing 3-Hz stimulation with postsyn-
aptic depolarization to 0 mV for 180 seconds, and LTD was
induced by pairing 1-Hz stimulation with postsynaptic depolar-
ization to 40 mV for 500 pulses. AMPA-mEPSCs were re-
corded at 60 mV in 100 M APV and analyzed as described
(9). Data are shown as mean  SEM; n is the number of cells or
cell pairs. For paired data we used Wilcoxon tests, and in other
cases we used unpaired Student’s t tests.
Two-Photon Laser-Scanning Microscopy and Image Analysis. Images
were collected on a custom-built two-photon microscope based
on the Fluoview system (Olympus, Center Valley, PA). The light
source was a mode-locked Ti:Sapphire laser (Chameleon; Co-
herent, Santa Clara, CA) tuned to 910 nm. The microscope was
equipped with a 	60, 0.9 N.A. water immersion lens. Images
were acquired in z-steps of 0.5 m and analyzed offline by using
software written in MatLab (MathWorks, Natick, MA). Back-
ground-subtracted integrated fluorescence was taken as a mea-
sure for spine volume after normalizing to mean fluorescence at
soma and large apical dendrite (22, 28). Spine types were scored
blindly. Experiments for shRNA and controls were conducted on
sister cultures.
Time-Lapse Imaging and Chemical LTP. For turnover experiments,
dendrites were imaged every 30 min at 30°C. In cLTP experi-
ments, dendrites were imaged for a 30-min baseline period, and
global changes were induced and measured as previously de-
scribed (22, 27). The age of cultures was 14 Div plus 3 days
expression, as the cLTP protocol was established for these
conditions. Changes in spine size and turnover were monitored
for 2 h after cLTP. Spine TOR was calculated as spines added
and lost between images and per micrometer of dendrite.
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